ECB steps up scrutiny of insurer-supported risk transfers, slowing approvals for complex synthetic SRTs and ruling out STS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results